On October 17, Director Huang Guo of the China Drug Administration met with Hong Kong Medical and Health Bureau Secretary Lu Chongmao and Director of Health Lam Man-kin and his entourage in Beijing. The two sides had in-depth exchanges on topics such as further strengthening cooperation between the Mainland and Hong Kong in drug supervision and supporting Hong Kong's drug regulatory capacity building. Lu Chung-mau said that the Hong Kong Drug Supervisory Authority is promoting the implementation of the Hong Kong Special Administrative Region's first five-year plan, comprehensively deepening pharmaceutical supervision reform, and will maintain close communication with the China Drug Administration in the future to help the high-quality development of the pharmaceutical industry. Lin Wenjian explained the situation of the upcoming Hong Kong Pharmaceutical Regulatory Centre and subsequent key tasks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.